The CEO of Eshmoun-Clinical Research, Dr. Souad Dziri, was the guest at the first International Congress of the Tunisian Society of Pharmacy Oncology to discuss the role of CROs in the implementation of clinical trials at the...
Eshmoun-Clinical Research, academic CRO dedicated to Clinical Research, is committed to the implementation of a training strategy dedicated to clinical research professions.
In partnership with the Medical Simulation Center, Eshmoun Clinical Research offered a first training in the profession of Clinical Research Associate (CRA) from March 11th to March 29th.
National experts in clinical research put their experience to the benefit of the participants. We mention, among others, Professor Hechmi Louzir, Professor Chadli Dziri, Dr. Chokri Jeribi, Professor Chawki Gueddas, Doctor Myriam Guerfali, Professor Samir Boubaker ... The students were also accompanied by international experts such as Pr Faiez Zannad and Doctor Cecile Dolinger and Professor Stephanie Grojean. Eshmoun Clinical-Research confirms its commitment to the promotion of medical research in Tunisia and its position as academic CRO.
Training similar to the different professions of clinical research and independent modular training are planned from September 2019.
Eshmoun-Clinical Research organized its launch ceremony at Dar El Jeld Hotel in the Medina of Tunis on April 19th, 2019 During this ceremony, Eshmoun's management board presented its missions and responsibilities throughout the Africa - Middle East region. A ceremony that distinguished itself by the quality of its audience, counting among its hosts the Minister of Health, CEO of public structures, international experts, National Clinical Research companies and local and international pharmaceutical industries.
Round table on the "State of challenges and perspectives of immunotherapy in Tunisia" organized at the BiotechPole Sidi Thabet during the celebration of World Immunology Day (April29th 2019) and in collaboration with the Tunisian Society of Immunology.
A very interesting debate was noted, driven by the presence of the various stakeholders in immunology field including Dr Souad Dziri, CEO of Eshmoun Clinical-Research as well as academics, researchers, public authorities, industry, doctors and patients.